The Botswana Medicines Regulatory Authority (BoMRA) invites interested principals, manufacturers and marketing authorisation holders (MAHs) to submit veterinary medicinal product (VMP) dossiers for registration through an expedited regulatory review pathway. This initiative supports BoMRA’s broader goal of enhancing access to quality-assured, safe, and effective veterinary medicines on the Botswana market.
This pathway is guided by BoMRA’s Reliance Policy, which recognises the regulatory decisions of competent authorities with established regulatory systems. Products submitted under this pilot will benefit from a shortened evaluation timeline of four (4) calendar months from the date of submission.
Expedited Review Window _ Pilot Phase 1: Key Information
• Submission Period or Window: 1 September – 30 November 2025
• Target KPI: 95% of received applications closed within TAT
• Target Registration Timeline: Applications will be concluded within 4 calendar months
• Objective: To increase treatment options available on the Botswana market
• Submission method: online through the BRIMS Self-Service Portal; the link is given below:https://brims.bomra.co.bw/#/public/ app-home
• Fees: Expedited Fee for registration as provided in the Fee Schedule; Screening Fee Discounted. Eligibility Criteria and Submission Requirements






